Le Lézard
Classified in: Health
Subjects: NPT, CHI, SVY

Brits in the Dark Over Eye Health Reveals Orbis UK


LONDON, June 12, 2019 /PRNewswire/ -- New research released today reveals that over half of Brits (53%) do not get their eyes tested every two years as recommended, and just over 1 in 10 (11%) can't remember the last time they went to the optician. This is despite 45% of those surveyed listing sight as their most valuable sense.

The survey also highlighted a disparity in attitudes to eye health based on age. Those aged 55 years and over are more than twice as likely to get their eyes tested every two years (62%) as 18-24 year olds (28%) ? however in a digital age, young people are at an increased risk of eye strain.

The poll of 2000 people was conducted by international eye care charity Orbis UK. With global blindness set to triple by 2050, the results highlight that Brits need to be more aware of how to protect their sight and more inclined to access the services the UK has to offer. 

Mr Larry Benjamin, consultant ophthalmic surgeon at Stoke Mandeville Hospital and a long-standing medical volunteer for the charity commented: "The results released today highlight a worrying lack of action when it comes to people's vision. Just 15% of those surveyed said that they felt knowledgeable about eye health.

"As an Orbis volunteer, I have trained fellow doctors all around the world and have seen the devastating consequences that a lack of access to eye care can have on someone's future. If people in developing countries are unable to seek help to have their cataract removed or receive a simple pair of glasses, adults and children can be plunged into poverty. We're very lucky that we have the NHS to help us when we experience difficulties."

UK parents of 0 ? 18 year olds are particularly uninformed when it comes to their children's sight - 78% were unaware that the NHS recommends children have their sight tested in reception (age 4-5) and almost one in five (18%) have never taken their child for an eye test. Only 13% of parents knew that glasses could be prescribed for children as young as 1 month old.

In many areas of the world where Orbis works, a lack of access to eye care for children can have lifelong repercussions, in some instances causing irreversible blindness if certain conditions are not caught in time. Children can be forced to drop out of school with issues such as refractive error, cataract and strabismus (severe squint) impacting their ability to see the blackboard, their textbooks or play with friends.

The charity launched their See My Future appeal in response to this and until 23rd June all donations will be doubled by the UK government, enabling Orbis to save the sight of twice as many adults and children across Africa and Asia.

Larry Benjamin continued: "Half of all childhood blindness is avoidable. Hopefully this survey will encourage people to get both their and their children's eyes tested more often, something many parents in other parts of the world aren't able to do as easily. By supporting Orbis's See My Future appeal, you could help prevent a life of unnecessary blindness.  Just £5.50 doubled to £11 could provide two new pairs of glasses to children struggling to see in school. Thanks to the UK government's Aid Match scheme, and the British public's generosity, Orbis's See My Future appeal will have twice the impact."

Discover how you can double your impact before the 23rd June by visiting: www.orbis.org.uk/en/see-my-future

 


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: